Variation in reported SARS-CoV-2 cases after testing policy changes.
作者信息
Halford Florence, Nash Sophie, Tessier Elise, Kall Meaghan, Dabrera Gavin
机构信息
COVID-19 Vaccines and Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK.
COVID-19 Vaccines and Epidemiology Division, UK Health Security Agency, London NW9 5EQ, UK.
出版信息
Lancet Infect Dis. 2022 Oct;22(10):1418-1419. doi: 10.1016/S1473-3099(22)00572-2. Epub 2022 Aug 23.
Abstract
摘要
相似文献
1
Variation in reported SARS-CoV-2 cases after testing policy changes.
Lancet Infect Dis. 2022 Oct;22(10):1418-1419. doi: 10.1016/S1473-3099(22)00572-2. Epub 2022 Aug 23.
2
Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
J Appl Lab Med. 2020 Jul 1;5(4):837-840. doi: 10.1093/jalm/jfaa076.
3
Update on rapid diagnostic testing for SARS-CoV-2.
Anaesth Crit Care Pain Med. 2022 Aug;41(4):101114. doi: 10.1016/j.accpm.2022.101114. Epub 2022 Jun 16.
4
Rapid roll out of SARS-CoV-2 antibody testing-a concern.
BMJ. 2020 Jun 24;369:m2420. doi: 10.1136/bmj.m2420.
5
Equitable distribution of SARS-CoV-2 tests.
Bull World Health Organ. 2022 Jun 1;100(6):411-412. doi: 10.2471/BLT.21.287398. Epub 2022 May 2.
6
SARS-CoV-2 self-testing: Handle with care.
Infect Dis Health. 2024 May;29(2):112-113. doi: 10.1016/j.idh.2023.12.002. Epub 2024 Feb 10.
7
SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored.
JAMA. 2022 Apr 5;327(13):1229-1230. doi: 10.1001/jama.2022.3382.
8
Is the Patient Infected with SARS-CoV-2?
J Clin Microbiol. 2021 Mar 19;59(4). doi: 10.1128/JCM.00147-21.
9
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
10
Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.
Indian J Med Res. 2020 May;151(5):424-437. doi: 10.4103/ijmr.IJMR_1896_20.
引用本文的文献
1
Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study.
J R Soc Med. 2024 Jun;117(6):202-211. doi: 10.1177/01410768231216332. Epub 2023 Dec 14.
2
Representativeness of whole-genome sequencing approaches in England: the importance for understanding inequalities associated with SARS-CoV-2 infection.
Epidemiol Infect. 2023 Sep 20;151:e169. doi: 10.1017/S0950268823001541.
3
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022.
Euro Surveill. 2023 Sep;28(36). doi: 10.2807/1560-7917.ES.2023.28.36.2300048.
4
The impact of COVID-19 on residents of long-term care facilities with learning disabilities and/or autism.
Influenza Other Respir Viruses. 2023 Apr 26;17(4):e13139. doi: 10.1111/irv.13139. eCollection 2023 Apr.
5
Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England.
J Infect. 2023 Jul;87(1):e8-e11. doi: 10.1016/j.jinf.2023.04.015. Epub 2023 Apr 24.
Zotero 插件